Cancer drug with better staying power, reduced toxicity promising in preclinical trial

A drug candidate has been found in preclinical trials to stop tumor growth entirely, deliver more cancer-busting power than many commonly used chemotherapy drugs and do so with fewer toxic side effects and more ability to overcome resistance.
Read More

Leave a comment